These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700 [TBL] [Abstract][Full Text] [Related]
6. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis. Lin CY; Lin CL; Kao CH Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261 [TBL] [Abstract][Full Text] [Related]
8. The Role of Preoperative Imaging in the Detection of Lateral Lymph Node Metastases in Rectal Cancer: A Systematic Review and Diagnostic Test Meta-analysis. Rooney S; Meyer J; Afzal Z; Ashcroft J; Cheow H; De Paepe KN; Powar M; Simillis C; Wheeler J; Davies J; Joshi H Dis Colon Rectum; 2022 Dec; 65(12):1436-1446. PubMed ID: 36102825 [TBL] [Abstract][Full Text] [Related]
9. Lymph nodes primary staging of colorectal cancer in 18F-FDG PET/MRI: a systematic review and meta-analysis. Ren Q; Chen Y; Shao X; Guo L; Xu X Eur J Med Res; 2023 May; 28(1):162. PubMed ID: 37143144 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer? Botsikas D; Bagetakos I; Picarra M; Da Cunha Afonso Barisits AC; Boudabbous S; Montet X; Lam GT; Mainta I; Kalovidouri A; Becker M Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of Samim M; Molenaar IQ; Seesing MFJ; van Rossum PSN; van den Bosch MAAJ; Ruers TJM; Borel Rinkes IHM; van Hillegersberg R; Lam MGEH; Verkooijen HM Surg Oncol; 2017 Mar; 26(1):37-45. PubMed ID: 28317583 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies. Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis. Kim DH; Kim SJ Clin Imaging; 2020 Sep; 65():100-107. PubMed ID: 32387798 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Niekel MC; Bipat S; Stoker J Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis. Kim SJ; Pak K; Kim K Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]